These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 28796930)

  • 1. Recurrence-associated gene signature optimizes recurrence-free survival prediction of colorectal cancer.
    Tian X; Zhu X; Yan T; Yu C; Shen C; Hu Y; Hong J; Chen H; Fang JY
    Mol Oncol; 2017 Nov; 11(11):1544-1560. PubMed ID: 28796930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 16-mRNA signature optimizes recurrence-free survival prediction of Stages II and III gastric cancer.
    Peng K; Chen E; Li W; Cheng X; Yu Y; Cui Y; Li Q; Wang Y; Xu X; Tang C; Gan L; Yu S; Liu T
    J Cell Physiol; 2020 Jul; 235(7-8):5777-5786. PubMed ID: 32048287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of a potent multi-mRNA signature for the prediction of early relapse in hepatocellular carcinoma.
    Cai J; Tong Y; Huang L; Xia L; Guo H; Wu H; Kong X; Xia Q
    Carcinogenesis; 2019 Jul; 40(7):840-852. PubMed ID: 31059567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide identification of a novel miRNA-based signature to predict recurrence in patients with gastric cancer.
    Yang Y; Qu A; Zhao R; Hua M; Zhang X; Dong Z; Zheng G; Pan H; Wang H; Yang X; Zhang Y
    Mol Oncol; 2018 Dec; 12(12):2072-2084. PubMed ID: 30242969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and predictive value of an autophagy-related signature for early relapse in stages I-III colon cancer.
    Mo S; Dai W; Xiang W; Li Y; Feng Y; Zhang L; Li Q; Cai G
    Carcinogenesis; 2019 Jul; 40(7):861-870. PubMed ID: 30933267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patients.
    Ji D; Qiao M; Yao Y; Li M; Chen H; Dong Q; Jia J; Cui X; Li Z; Xia J; Gu J
    EBioMedicine; 2018 Sep; 35():189-197. PubMed ID: 30166271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Five-Gene Signature for Recurrence Prediction of Hepatocellular Carcinoma Patients.
    Wang Z; Zhang N; Lv J; Ma C; Gu J; Du Y; Qiu Y; Zhang Z; Li M; Jiang Y; Zhao J; Du H; Zhang Z; Lu W; Zhang Y
    Biomed Res Int; 2020; 2020():4037639. PubMed ID: 33163533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of a gene signature in clear cell renal cell carcinoma.
    Chen L; Luo Y; Wang G; Qian K; Qian G; Wu CL; Dan HC; Wang X; Xiao Y
    J Cell Physiol; 2019 Jul; 234(7):10324-10335. PubMed ID: 30417359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large-Scale Analysis of Gene Expression Data Reveals a Novel Gene Expression Signature Associated with Colorectal Cancer Distant Recurrence.
    Alajez NM
    PLoS One; 2016; 11(12):e0167455. PubMed ID: 27935967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a 4-mRNA metastasis-related prognostic signature for patients with breast cancer.
    Xie X; Wang J; Shi D; Zou Y; Xiong Z; Li X; Zhou J; Tang H; Xie X
    J Cell Mol Med; 2019 Feb; 23(2):1439-1447. PubMed ID: 30484951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
    Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
    Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.
    Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H
    J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of Immune-Associated Nomogram for Predicting the Recurrence Survival Risk of Stage I Cervical Cancer.
    Wang Y; Zhang L; Wang B; Cheng Y
    Biomed Res Int; 2021; 2021():6699131. PubMed ID: 34337046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of an 8-Gene Signature to Improve Survival Prediction of Colorectal Cancer.
    Zhou L; Yu Y; Wen R; Zheng K; Jiang S; Zhu X; Sui J; Gong H; Lou Z; Hao L; Yu G; Zhang W
    Front Oncol; 2022; 12():863094. PubMed ID: 35619909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of a hypoxia-related microRNA signature in patients with colorectal cancer.
    Yang Y; Qu A; Wu Q; Zhang X; Wang L; Li C; Dong Z; Du L; Wang C
    Aging (Albany NY); 2020 Jan; 12(1):35-52. PubMed ID: 31926112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A robust gene signature for the prediction of early relapse in stage I-III colon cancer.
    Dai W; Li Y; Mo S; Feng Y; Zhang L; Xu Y; Li Q; Cai G
    Mol Oncol; 2018 Apr; 12(4):463-475. PubMed ID: 29377588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene signatures predict biochemical recurrence-free survival in primary prostate cancer patients after radical therapy.
    Su Q; Liu Z; Chen C; Gao H; Zhu Y; Wang L; Pan M; Liu J; Yang X; Tian J
    Cancer Med; 2021 Sep; 10(18):6492-6502. PubMed ID: 34453418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a lipogenic genes panel for diagnosis and recurrence of colorectal cancer.
    Gharib E; Nasrinasrabadi P; Zali MR
    PLoS One; 2020; 15(3):e0229864. PubMed ID: 32155177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
    Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
    JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.